Drug Markets/Miglitol

Miglitol

3 NDCs across 1 manufacturer|3 Generic,0 Brand

Miglitol is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 18, 1996, and the first generic was approved Feb 24, 2015. In 2024, Medicare Part D spent $495K on Miglitol across 1,658 claims for 419 beneficiaries.

Miglitol is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $1.75 to $2.03 per EA — a 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

1

competing in market

Price Spread

$1.75 – $2.03

per EA

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing MIGLITOL

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Miglitol used to treat?

Miglitol is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

When did Miglitol become available as a generic?

FDA approved the first generic Miglitol (ANDA) on Feb 24, 2015.

How much does Medicare spend on Miglitol?

In 2024, Medicare Part D spent $495K on Miglitol across 1,658 claims for 419 beneficiaries.

How many Miglitol products are on the market?

The Miglitol drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.

What is the price range for Miglitol?

NADAC reference prices for Miglitol range from $1.7545 to $2.0312 per EA — a 16% difference between cheapest and most expensive.

Which manufacturers make Miglitol?

1 manufacturer lists Miglitol in NADAC. Ranked by number of NDCs, the largest are Westminster Pharmaceuticals LLC (3).